Actinium Strengthens IP Portfolio for Radiotherapy Programs
NEW YORK, May 29, 2026 Actinium Pharmaceuticals, Inc. has announced the receipt of two patent allowances from the Canadian...
oncology innovation
Advertisement
Johnson & Johnson’s RYBREVANT FASPRO Shows Strong HNSCC Results
CHICAGO, Illinois, May 31, 2026 Johnson & Johnson has reported pivotal results from the Phase 1b/2 OrigAMI-4 study, demonstrating...
GRAIL’s Galleri® Test Increases Cancer Detection 6.5-Fold in PATHFINDER 2 Study
MENLO PARK, California, May 31, 2026 GRAIL, Inc. has unveiled compelling new results from its registrational PATHFINDER 2 study,...
Antengene Expands Oncology Pipeline With Phase III ATG-022 Gastric Cancer Trial
SHANGHAI and HONG KONG, China, May 28, 2026 Antengene has announced a major clinical development milestone after receiving endorsement...
Pfizer and Innovent Forge $10.5B Global Oncology Alliance
NEW YORK, SAN FRANCISCO, and SUZHOU, China, May 28, 2026 Pfizer Inc. and Innovent Biologics have announced a landmark...
Advertisements
Virax Biolabs Reports Positive Long COVID Data
LONDON, United Kingdom, May 26, 2026 Virax Biolabs Group Limited has announced encouraging early clinical data for ViraxImmune™, its...
Citius Oncology LYMPHIR ASCO Phase 1 Data
CRANFORD, New Jersey, May 26, 2026 Citius Oncology, Inc. has announced that new Phase 1 clinical study data evaluating...
Nanobiotix Expands Oncology Pipeline With $100M Funding
Paris, France and Cambridge, Massachusetts, USA, May 22, 2026 Nanobiotix, a late-stage clinical biotechnology company specializing in physics-based cancer...
AstraZeneca and Daiichi Sankyo Advance Enhertu in Tumour-Agnostic Oncology
Cambridge, United Kingdom – May 22, 2026 AstraZeneca and Daiichi Sankyo announced that the European Medicines Agency’s Committee for...
Datar Cancer Genetics Receives Landmark FDA Approval for CellDx-Tissue
NASHIK, India, May 21, 2026 Datar Cancer Genetics (DCG) has achieved a major milestone in precision oncology after receiving...
Advertisement
